Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Alexandria › NPI 1477500015
Hospital

Rapides Healthcare System, L.L.C.

Rapides Healthcare System, L.L.C. was paid $26.89M by Medicaid between Jan 2018 and Dec 2024, across 231 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoRAPIDES HEALTHCARE SYSTEM, L.L.C.
ALEXANDRIA, LA 71301
33aNPI1477500015assigned 05/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.89M
24GClaims1,128,412
24DCodes billed231
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#18 of 96
Median peer was paid$5.17M
This provider vs. median5.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018170,656$3.78M
2019170,409$3.98M
2020115,973$2.71M
2021146,172$3.27M
2022189,363$4.45M
2023183,201$4.55M
2024incomplete152,638$4.15M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 111,960 103,660 $4.51M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 78,836 71,069 $4.38M
74177 Computed tomography, abdomen and pelvis; with contrast material 7.3% 2,379 2,187 $1.96M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6.3% 50,503 45,358 $1.71M
70450 Computed tomography, head or brain; without contrast material 5.2% 6,576 5,827 $1.40M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 3.7% 15,480 13,612 $983K
85027 2.4% 129,771 114,946 $638K
J7030 Infusion, normal saline solution , 1000 cc 2.4% 17,669 15,750 $633K
71046 Radiologic examination, chest; 2 views 2.3% 13,909 12,927 $625K
87631 2.3% 4,915 4,478 $615K
80053 Comprehensive metabolic panel 2.1% 70,938 63,690 $575K
71045 Radiologic examination, chest; single view 1.9% 25,024 22,274 $511K
219 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.9% 10,714 $505K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.7% 32,210 $464K
76818 1.4% 2,365 $379K
J0696 Injection, ceftriaxone sodium, per 250 mg 1.3% 4,848 $348K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.2% 10,493 $335K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.2% 10,487 $335K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,891 $258K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,147 $249K
84443 Thyroid stimulating hormone (TSH) <1% 16,578 $225K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,107 $223K
G0378 Hospital observation service, per hour <1% 1,975 $219K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 6,054 $192K
99214 Doctor's office visit, returning patient (more involved) <1% 3,866 $182K
74150 <1% 528 $174K
81001 <1% 68,607 $162K
84484 <1% 20,467 $158K
87086 Culture, bacterial; quantitative colony count, urine <1% 19,623 $136K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,432 $135K
80048 Basic metabolic panel (calcium, ionized) <1% 19,602 $133K
80061 Lipid panel <1% 11,964 $130K
36415 Collection of venous blood by venipuncture <1% 51,046 $128K
99285 Emergency room visit (most serious) <1% 1,629 $103K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,959 $102K
74018 <1% 3,299 $98K
83036 Hemoglobin; glycosylated (A1C) <1% 12,086 $91K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,188 $90K
80076 <1% 12,996 $89K
94060 <1% 696 $87K
86738 <1% 6,867 $87K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,435 $86K
76801 <1% 1,002 $84K
81025 <1% 12,624 $82K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,361 $76K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,209 $73K
87653 <1% 2,150 $72K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 5,476 $69K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,772 $66K
0240U <1% 833 $63K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,154 $59K
80074 <1% 1,474 $58K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,626 $57K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,438 $57K
73562 <1% 1,307 $57K
20610 <1% 2,106 $56K
83690 <1% 9,645 $55K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,685 $54K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 505 $50K
87808 <1% 3,830 $48K
83735 <1% 9,755 $46K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 537 $44K
87070 <1% 5,122 $43K
84439 <1% 5,946 $43K
83605 <1% 5,735 $43K
83874 <1% 6,153 $40K
72125 Computed tomography, cervical spine; without contrast material <1% 164 $38K
82553 <1% 5,566 $38K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 515 $36K
86803 <1% 3,045 $35K
59025 Fetal non-stress test <1% 297 $35K
99203 Doctor's office visit, new patient (routine) <1% 1,201 $34K
84703 <1% 5,254 $32K
87340 <1% 3,752 $32K
96375 Therapeutic injection; each additional sequential IV push <1% 2,975 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,822 $30K
94729 <1% 413 $30K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 937 $28K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,105 $27K
94726 <1% 325 $27K
83655 <1% 2,107 $26K
83880 <1% 1,185 $25K
86592 <1% 6,298 $25K
73630 <1% 745 $25K
86308 <1% 4,505 $23K
87400 <1% 1,562 $23K
87390 <1% 998 $19K
84146 <1% 1,144 $19K
J7050 Infusion, normal saline solution, 250 cc <1% 808 $18K
80047 <1% 2,398 $17K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 41 $15K
85610 <1% 6,172 $15K
82731 <1% 723 $15K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 14 $14K
84425 <1% 604 $13K
86703 <1% 1,173 $12K
87040 <1% 1,236 $12K
85730 <1% 3,613 $12K
73610 <1% 342 $11K
82607 <1% 832 $11K
84702 <1% 856 $11K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 88 $11K
87077 <1% 991 $9K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 121 $9K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 56 $8K
C1892 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away <1% 94 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 532 $8K
86850 <1% 2,357 $8K
81003 <1% 3,248 $7K
82550 <1% 1,747 $7K
86762 <1% 570 $7K
87205 <1% 1,731 $7K
73130 <1% 189 $6K
84112 <1% 80 $6K
76830 Ultrasound, transvaginal <1% 60 $6K
73110 <1% 146 $6K
86901 <1% 3,127 $5K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,724 $5K
86900 <1% 3,111 $5K
90686 <1% 1,417 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,197 $5K
87905 <1% 596 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,243 $4K
82150 <1% 808 $4K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 1,284 $4K
72131 <1% 14 $4K
C1769 Guide wire <1% 180 $3K
86140 <1% 651 $3K
86694 <1% 169 $3K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 14 $3K
80164 <1% 226 $2K
82043 <1% 435 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 609 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 2,440 $2K
84481 <1% 278 $2K
Q0222 Injection, bebtelovimab, 175 mg <1% 21 $2K
87634 <1% 37 $2K
82570 <1% 435 $2K
82746 <1% 210 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 2,071 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 727 $2K
99204 Doctor's office visit, new patient (more involved) <1% 46 $2K
94727 <1% 27 $2K
72100 <1% 56 $2K
83001 <1% 122 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 78 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,206 $2K
87186 <1% 208 $2K
82077 <1% 187 $2K
86787 <1% 162 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 56 $1K
77336 <1% 45 $1K
70100 <1% 67 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 138 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 107 $1K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 6,278 $985.65
73030 <1% 27 $915.67
84134 <1% 169 $870.44
86235 <1% 15 $850.51
82950 <1% 195 $800.81
84145 <1% 29 $667.47
80179 <1% 59 $579.96
84153 <1% 37 $557.62
58100 <1% 95 $556.60
83970 <1% 13 $544.94
72040 <1% 13 $516.58
83615 <1% 105 $514.44
87501 <1% 48 $471.06
90715 <1% 14 $458.64
87276 <1% 36 $434.54
87529 <1% 15 $423.88
87299 <1% 37 $417.12
85652 <1% 197 $415.78
82652 <1% 53 $415.32
96361 Intravenous infusion, hydration; each additional hour <1% 237 $401.16
87260 <1% 36 $399.71
84550 <1% 100 $394.21
87280 <1% 36 $378.24
82248 <1% 115 $376.06
87275 <1% 36 $359.95
86141 <1% 45 $338.48
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 88 $320.20
S0028 Injection, famotidine, 20 mg <1% 107 $312.36
92133 <1% 192 $311.25
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 16 $310.27
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 526 $289.41
84403 <1% 12 $287.55
82670 <1% 13 $283.88
84402 <1% 12 $283.74
87081 <1% 57 $277.09
J3010 Injection, fentanyl citrate, 0.1 mg <1% 801 $242.26
85014 <1% 104 $235.96
85018 <1% 101 $227.91
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit <1% 64 $219.90
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 413 $195.46
87279 <1% 73 $188.81
J8540 Dexamethasone, oral, 0.25 mg <1% 163 $187.88
83516 <1% 15 $161.74
85045 <1% 44 $156.81
82728 <1% 15 $152.09
J1644 Injection, heparin sodium, per 1000 units <1% 79 $151.71
86038 <1% 14 $151.31
57454 <1% 36 $147.50
86039 <1% 18 $147.28
82247 <1% 40 $118.14
90714 <1% 16 $102.20
J0690 Injection, cefazolin sodium, 500 mg <1% 106 $99.15
84480 <1% 12 $85.88
82270 <1% 32 $85.18
S0077 Injection, clindamycin phosphate, 300 mg <1% 29 $75.78
86431 <1% 13 $74.92
84270 <1% 12 $69.48
84436 <1% 12 $64.24
83540 <1% 13 $57.06
84100 <1% 13 $56.97
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 36 $40.92
J2704 Injection, propofol, 10 mg <1% 503 $37.41
G0008 Administration of influenza virus vaccine <1% 1,928 $28.95
J3480 Injection, potassium chloride, per 2 meq <1% 51 $26.91
J2550 Injection, promethazine hcl, up to 50 mg <1% 44 $25.70
J7614 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg <1% 33 $18.35
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 13 $14.43
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 22 $14.19
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 14 $9.38
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 54 $6.64
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 29 $4.91
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 107 $0.00
92015 Determination of refractive state 0% 39 $0.00
92134 0% 15 $0.00
A9270 Non-covered item or service 0% 324 $0.00
87632 0% 69 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAVIS, DANIEL (CFO)
Same official

Other billing entities under DAVIS, DANIEL

Full network →
ProviderLocationPaid
Hca Health Services of Oklahoma INCOklahoma City, OK$692K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.